NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 114.16 billion as of March 9, 2026. Its market cap has increased by 86.92% in one year.

Market Cap

114.16B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

74.08

Stock Price

8,890.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 114.16B, an increase of 53.05%. That is a compound annual growth rate of 4.88%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	114.16B	-30.26%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
ViGenCell	114.39B
BIO-FD&C	122.00B
CORESTEMCHEMON	123.54B
IMGT Co.,Ltd.	106.96B
Quratis	103.62B
TegoScience	103.44B
Progen	100.55B
Cell Biotech	96.29B

Market Cap Rankings